Home
About BioMark
Oncology Platform
- Biomark SSAT1 Assay
- BioMark Metabolic Panel
Investor Relations
Bio-Stream Diagnostics
- Bio-Stream Spectral Test
Recent Posts
Info & Contact

News Releases

« Back to News

BioMark Announces OTCQB Listing

February 17, 2015

Press release – BIOMARK ANNOUNCES OTCQB LISTING- February 17th (PDF)

———————————————

< BioMark Receives US Trading Symbol BMKDF from FINRA and Commences Trading in the USA Biomark Announces A Final Closing Private Placement >

ARCHIVES

2020 News Release

2019 News Release
2018 News Release
2017 News Release
2016 News Release
2015 News Release
2014 News Release

Further information about BioMark is available under its profile on:

SEDAR website:

http://www.sedar.com

CSE website:

http://thecse.com

Sitemap

Home
About BioMark
Oncology Platform
- Biomark SSAT1 Assay
- BioMark Metabolic Panel
Investor Relations
Bio-Stream Diagnostics
- Bio-Stream Spectral Test
Recent Posts
Info & Contact

Latest Posts

Cancer that went undetected during the pandemic an ‘impending disaster,’ specialists warn
Missing cancer cases a worrying pandemic trend
World Cancer Day: A leading international awareness day
Doctors fear an impending wave of cancer patients after COVID-19 delays
Richmond company looking for ‘holy grail’ in COVID-19 testing

Site Policies

Terms and Conditions
Website and Privacy Policy

Contact Us

INVESTOR CORPORATE INQUIRES

RASHID A. BUX

CEO
604.370.0779
info@biomarkdiagnostics.com

Copyright © 2019 BioMark Diagnostics Inc. All rights reserved.

BioMark's mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.